Cellectis S.A. Cash Conversion Cycle 2011-2026 | CLLS

Annual Cash Conversion Cycle Cellectis S.A.

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	-	-	-	-	-	-839	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
-839	-839	-839

Cash Conversion Cycle of other stocks in the Biotechnology industry

Issuer	Cash Conversion Cycle	Price	% 24h	Market Cap	Country
Aptorum Group Limited APM	-400	$ 1.06	-0.93 %	$ 5.78 M	China
Adagene ADAG	53.8	$ 1.65	-	$ 92.9 M	China
Arrowhead Pharmaceuticals ARWR	8.75	$ 64.9	-0.15 %	$ 8.68 B	USA
Alexion Pharmaceuticals, Inc. ALXN	12.8	-	-	$ 40.3 B	USA
AgeX Therapeutics AGE	-8.96 K	-	-10.17 %	$ 12.2 K	USA
Biogen BIIB	387	$ 187.4	0.75 %	$ 27.3 B	USA
EyeGate Pharmaceuticals, Inc. EYEG	17	-	-1.52 %	$ 24.7 M	USA
Albireo Pharma ALBO	-1.55 K	-	-0.23 %	$ 916 M	USA
Midatech Pharma plc MTP	82.8	-	-18.52 %	$ 27.3 M	Britain
Alpine Immune Sciences ALPN	154	-	-	$ 2.17 B	USA
BioXcel Therapeutics BTAI	-2.28 K	$ 1.98	-1.0 %	$ 5.02 M	USA
CASI Pharmaceuticals CASI	11.9	$ 1.04	-2.34 %	$ 142 M	USA
Ampio Pharmaceuticals AMPE	-2.85 K	-	-11.43 %	$ 502 K	USA
Catalyst Biosciences CBIO	391	$ 10.74	-2.1 %	$ 707 M	USA
Arena Pharmaceuticals ARNA	946	-	-6.81 %	$ 3.04 B	USA
AIkido Pharma AIKI	17.9	-	1.93 %	$ 17.4 M	USA
Celldex Therapeutics CLDX	-6.08 K	$ 27.0	-1.28 %	$ 1.74 M	USA
Институт стволовых клеток человека ISKJ	104	-	-	-	Russia
Acasti Pharma ACST	1.97	-	4.01 %	$ 150 M	Canada
Adaptimmune Therapeutics plc ADAP	25	-	-15.15 %	$ 60.3 M	Britain
Amphastar Pharmaceuticals AMPH	166	$ 27.75	0.02 %	$ 1.34 B	USA
Biohaven Pharmaceutical Holding Company Ltd. BHVN	209	$ 11.13	-2.02 %	$ 720 M	USA
BioDelivery Sciences International BDSI	340	-	-4.8 %	$ 255 M	USA
Axon Enterprise AXON	86.2	$ 633.45	3.34 %	$ 48 B	USA
Ayala Pharmaceuticals AYLA	-2.15 K	-	-	$ 7.46 M	Israel
Aytu BioScience AYTU	174	$ 2.64	-0.75 %	$ 16.6 M	USA
BeiGene, Ltd. BGNE	49.5	-	0.49 %	$ 251 B	Cayman-islands
AstraZeneca PLC AZN	-58	$ 94.65	0.68 %	$ 96.9 B	Britain
Bellicum Pharmaceuticals BLCM	6.09	-	-9.72 %	$ 5.89 M	USA